神経学および神経科学ジャーナル

  • ISSN: 2171-6625
  • ジャーナル h-index: 17
  • 雑誌引用スコア: 4.43
  • ジャーナルのインパクトファクター: 3.38
インデックス付き
  • Jゲートを開く
  • Genamics JournalSeek
  • グローバル インパクト ファクター (GIF)
  • 中国国家知識基盤 (CNKI)
  • 研究ジャーナル索引作成ディレクトリ (DRJI)
  • OCLC-WorldCat
  • プロクエスト召喚
  • 科学雑誌インパクトファクター (SJIF)
  • ユーロパブ
  • Google スカラー
  • 秘密検索エンジン研究所
このページをシェアする

抽象的な

Reproductive Health, Social and Financial Impact of Valproic Acid Withdrawal for Childbearing Epileptic Saudi Woman

Narjes Mokni1*, Neveen Fathi2, Miraven Mupas1, Said Moussa1, Assem Mustafa3, Tamir Abdeljawad4, Bashir Ighle2, Hassen Al Dawssary5

Epilepsy complicates a woman`s reproductive life. The physiological modification of the woman and the effects of antiepileptic drugs are generally the cause. Several complications may be added during treatment that requires careful monitoring. The risks in women of childbearing age associated with prenatal Valproic Acid Drug (VPA) exposure are becoming established, and updated recommendations are being made internationally for restrictions to (VPA) use and enhanced preconception counseling in this patient group.

To minimize these complications we implement same protocol in the different hospital departments to assure high quality of care for childbearing age women. As a result we remark a decrease number of patients using (VPA) and improvement of the quality of reproductive health and per consequence reducing hospital and societal costs.